Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Net Revenue and Operating Profit of Each Segment (Detail)

v3.3.1.900
Segment Reporting - Net Revenue and Operating Profit of Each Segment (Detail) - USD ($)
 3 Months Ended
Feb. 29, 2016
Feb. 28, 2015
Nov. 30, 2015
Segment Reporting Information [Line Items]      
Total net revenue $ 5,152,198 $ 4,843,381  
Total cost of sales 1,348,291 1,273,987  
Total depreciation and amortization 41,548 18,242  
Total operating income 156,422 625,191  
Total interest expense 261,334 301,286  
Total income tax expense 0 $ 25,412  
Total assets 19,100,158   $ 19,497,946
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]      
Segment Reporting Information [Line Items]      
Total net revenue 5,020,459    
Total cost of sales 1,245,023    
Total depreciation and amortization 28,678    
Total operating income 127,951    
Total interest expense 246,943    
Total income tax expense 0    
Total assets 16,349,269   16,697,621
Prepacyte CB [Member]      
Segment Reporting Information [Line Items]      
Total net revenue 131,739    
Total cost of sales 103,268    
Total depreciation and amortization 12,870    
Total operating income 28,471    
Total interest expense 14,391    
Total income tax expense 0    
Total assets $ 2,750,889   $ 2,800,325